Figure 1: Representative immunoblots, p53 antibody specificity, subcellular enrichment and protein loading controls.

(a) Representative immunoblots corresponding to total and phosphorylated protein content measured in the nuclear and cytosolic fractions, before (Pre), immediately (+0 h) and 3 h (+3 h) after the CE and SIE trials. p-p38 MAPKThr180/Tyr182: bottom band at ~38 kDa; PHF20: top band at ~105 kDa. No band was detected in the nuclear fractions for p-ACCSer79. (b) Confirmation of the p53 antibody specificity; samples were run beside an untagged full length p53 recombinant human protein and blotted against both total-p53 (positive control) and p-p53Ser15 (negative control) antibodies. S: sample; RP: p53 recombinant protein. (c) Histone H3 and LDHA were used as indicators of cytosolic and nuclear enrichment, respectively. N: nuclear fractions; C: cytosolic fractions. (d) Whole-lane Coomassie blue staining for both nuclear and cytosolic fractions, and (e) histone H3 (nuclear) and GAPDH (cytosolic), were used to verify equal loading between lanes. The immunoblot and whole-lane Coomassie images in this figure were cropped to improve the conciseness and clarity of the presentation.